Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Arrowhead Pharmaceuticals)"
Count: 25
Selected: 0
NCT IDTitle
NCT05083364Study of ARO-C3 in Adult Healthy Volunteers and Patients With Paroxysmal Nocturnal Hemoglobinuria and Complement-Mediated Renal Disease
NCT04998201Study of ARO-APOC3 in Adults With Mixed Dyslipidemia
NCT04832971Study of ARO-ANG3 in Adults With Mixed Dyslipidemia
NCT04720534Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia
NCT04375514Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis
NCT04202354Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH
NCT04169711Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT03946449Study of ARO-AAT in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD)
NCT03945292Safety, Tolerability and Pharmacodynamic Effect of ARO-AAT
NCT03783377Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)
NCT03747224Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients
NCT03365947Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)
NCT03362242Study of ARO-AAT in Normal Adult Volunteers
NCT02900183Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels
NCT02797522A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)
NCT02738008Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection
NCT02604212A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection
NCT02604199A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection
NCT02577029Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)
NCT02535416A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers
NCT02452528Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus
NCT02363946A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)
NCT02349126Study of ARC-520 in Patient With Chronic Hepatitis B Virus
NCT02065336A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
NCT01872065Safety and Tolerability Study of ARC-520 in Healthy Volunteers